Conn. Jury Hands Boehringer 3rd Straight Pradaxa Trial Win

Boehringer Ingelheim Pharmaceuticals has won its third straight bellwether trial over the alleged bleeding risk of its blood thinner Pradaxa, after a Connecticut state jury rejected a man's claims that the...

Already a subscriber? Click here to view full article